Form 4: Jazz Pharmaceuticals Executive Reports Stock Transaction
Insider Transaction (Form 4)
Mary Elizabeth Henderson, SVP, Technical Operations of Jazz Pharmaceuticals plc, reported multiple transactions in common stock on September 8, 2026.
Summary
- Tax/exercise-price withholding: disposed of 1,412 Ordinary Shares at $243.03 ($343,158) on September 8, 2026; holds 23,830 after (Direct).
- Tax/exercise-price withholding: disposed of 15 Ordinary Shares at $241.20 ($3,618) on September 8, 2026; holds 23,815 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Mary Elizabeth Henderson — Officer (SVP, Technical Operations)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-08 | Tax/exercise-price withholding | Ordinary Shares | 1,412 | $243 | $343.2K | 23,830 |
| 2026-09-08 | Tax/exercise-price withholding | Ordinary Shares | 15 | $241 | $3.6K | 23,815 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-08 | Tax/exercise-price withholding (1,412 shares) |
| 2026-09-08 | Tax/exercise-price withholding (15 shares) |
Keywords
insider transaction, Form 4, JAZZ, Jazz Pharmaceuticals plc, neutral, Mary Elizabeth Henderson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.